Online risk scores for pre- and postoperative prediction of early recurrence in hepatocellular carcinoma patients undergoing conversion liver resection after tyrosine kinase inhibitors and immune checkpoint inhibitors therapy.
Lin KY, Liu HZ, Liu JW, Zhu XD, Pan YX, Shen SL, Zhang W, Jin RA, Han CY, Chen J, Zhang XY, Liang BY, Zhang YD, Ma J, Wang NY, Li DX, Xiong R, Li ZC, Li JD, Zhang ZB, Chen JH, Chen YF, Zheng L, Zhao L, Yin T, Li DY, Zhang L, Li XC, Huang ZY, Wen TF, Chen YJ, Peng T, Liang X, Song TQ, Kuang M, Xu L, Wang K, Sun HC, Zeng YY; China Liver Cancer Study Group Young Investigators (CLEAP).
Lin KY, et al. Among authors: xiong r.
Eur J Surg Oncol. 2025 Jun 16;51(9):110220. doi: 10.1016/j.ejso.2025.110220. Online ahead of print.
Eur J Surg Oncol. 2025.
PMID: 40544714